Skip to content
  • Sunday, 26 July 2026
  • 2:57 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Competition Between Amyloid Beta and Tau for Microtubule Binding Sites Offers New Insight into the Early Pathogenesis of Alzheimer’s Disease
Neuroscience & Brain Research

Competition Between Amyloid Beta and Tau for Microtubule Binding Sites Offers New Insight into the Early Pathogenesis of Alzheimer’s Disease

Rifan Muazin Jun 27, 2026 0

Researchers at the University of California, Riverside (UCR) have unveiled a provocative new theory regarding the molecular origins of Alzheimer’s…

Read More
Data Science & Bioinformatics

Olostep Emerges as a Streamlined Solution for AI-Ready Web Data Extraction from Documentation Sites, Outpacing Traditional Crawling Frameworks.

Evan Lee Salim Apr 20, 2026 0

The landscape of data acquisition for artificial intelligence (AI) is undergoing a significant transformation, driven by the escalating demand for…

Read More
Indiana University Researchers Revolutionize Bone Marrow Imaging with Breakthrough Multiplex Technique to Advance Disease ResearchRobotic Phlebotomy Study Signals Automation Shift for Clinical LabsSalk Institute Researchers Identify BCL6 Protein as Key to Preventing Muscle Loss During Weight Loss and AgingShining New Light on the Secret World of Cell-to-Cell Communication
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ